Related Experiment Video
Updated: Sep 16, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B
David van Duin1, Arturo Casadevall, Joshua D Nosanchuk
1Department of Medicine, Division of Infectious Diseases. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
The fungal pathogens Cryptococcus neoformans and Histoplasma capsulatum produce melanin-like pigments in the presence of L-dopa in vitro and during mammalian infection. We investigated whether melanization affected the susceptibilities of the fungi to amphotericin B, caspofungin, fluconazole, itraconazole, or flucytosine (5FC). Using the standard macrodilution MIC protocol (the M27A protocol) of the National Committee for Clinical Laboratory Standards for yeast, we found no difference in the susceptibilities of melanized and nonmelanized C. neoformans and H. capsulatum isolates. Killing assays demonstrated that melanization reduced the susceptibilities of both fungi to amphotericin B and caspofungin. Laccase-deficient C. neoformans cells grown with L-dopa were significantly more susceptible than congenic melanin-producing yeast to killing by amphotericin B or caspofungin. Preincubation of amphotericin B or caspofungin with melanins decreased their antifungal activities. Elemental analysis of melanins incubated with amphotericin B or caspofungin revealed an alteration in the C:N ratios of the melanins, which indicated binding of these drugs by the melanins. In contrast, incubation of fluconazole, itraconazole, or 5FC with melanins did not significantly affect the antifungal efficacies of the drugs or the chemical composition of the melanins. The results suggest a potential explanation for the inefficacy of caspofungin against C. neoformans in vivo, despite activity in vitro. Furthermore, the results indicate that fungal melanins protect C. neoformans and H. capsulatum from the activities of amphotericin B and caspofungin and that this protection is not demonstrable by standard broth macrodilution assays.
Insights
Fungal melanin protects against certain antifungal drugs, but standard tests miss this effect. This finding explains treatment failures and highlights melanin's protective role against amphotericin B and caspofungin.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
- Fungal Pathogenesis
Background:
- Cryptococcus neoformans and Histoplasma capsulatum produce melanin.
- Melanin production occurs in vitro and during infection.
- The impact of fungal melanin on antifungal drug susceptibility is not fully understood.
Purpose of the Study:
- To investigate if fungal melanization affects susceptibility to key antifungal drugs.
- To determine the mechanism by which melanin might alter drug efficacy.
- To correlate in vitro findings with potential in vivo clinical observations.
Main Methods:
- Standardized broth macrodilution assays (MIC testing).
- Fungal killing assays with melanized and non-melanized yeasts.
- Incubation of antifungal drugs with purified fungal melanins.
- Elemental analysis (C:N ratios) of drug-melanin interactions.
Main Results:
- Melanization did not alter minimum inhibitory concentrations (MICs) for any tested drug.
- Killing assays showed melanization reduced susceptibility to amphotericin B and caspofungin.
- Melanins bound to amphotericin B and caspofungin, altering their chemical composition.
- Fluconazole, itraconazole, and flucytosine efficacy was unaffected by melanin.
Conclusions:
- Fungal melanin confers resistance to amphotericin B and caspofungin.
- Standard MIC assays do not detect melanin-mediated drug resistance.
- Melanin binding explains reduced efficacy of certain antifungals against Cryptococcus and Histoplasma.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

